this invention relates to compounds of the formula ## str2 ## wherein r is cycloalkyl , aryl , substituted aryl , aralkyl or substituted aralkyl . preferred compounds of the invention are those in which r is cycloalkyl of three to six carbon atoms , phenyl , substituted phenyl , phenylalkyl or substituted phenylalkyl . in substituted aryl ( including substituted phenyl ) and substituted aralkyl ( including substituted phenylalkyl ), the aryl moiety is either monosubstituted or disubstituted , and each substituent is selected from the group consisting of halogen ( preferably chlorine ), amino , nitro , hydroxy , lower alkyl or lower alkoxy . the alkyl moiety of aralkyl has one to three carbon atoms and joins the aralkyl group to the rest of the compound ( for example , aralkyl is benzyl when the alkyl group has one carbon atom ). in substituted phenyl , substitution can occur at the ortho , meta or para positions . lower alkyl and lower alkoxy contain 1 to 4 carbon atoms and are straight - chained or branched . the compounds of this invention can be formed by the following reaction : ## str3 ## involving 2 - adamantanone oxime [ compound i ] and an appropriate isocyanate derivative [ compound ii ]. r is defined above . preferred reaction conditions are given in example 1 . the following examples are illustrative . they are not intended to limit the invention . to a cooled solution ( ice - water at 10 ° c .) of 2 - adamantanone oxime ( 5 . 0 g , 0 . 03 mol ) in 300 ml dichloromethane was added dropwise cyclohexyl isocyanate ( 3 . 77 g , 0 . 03 mol ) in dichloromethane ( 25 ml ). the resulting solution was stirred at 10 ° c . for 3 - 4 h , then the solvent was evaporated under reduced pressure to yield the title compound , tricyclo [ 3 . 3 . 1 . 1 3 , 7 ] decane - 2 - one o -[( cyclohexyl ) aminocarbonyl ] oxime . after repeated crystallization from ether - hexane , 6 . 2 g of the title compound were obtained as white crystals ( m . p ., 110 °- 112 ° c .). anal . calc &# 39 ; d for c 17 h 26 n 2 o 2 : c , 70 . 31 ; h , 9 . 02 ; n , 9 . 65 . found : c , 70 . 73 ; h , 8 . 98 ; n , 9 . 56 . substitution of an equivalent quantity of phenyl isocyanate for cyclohexyl isocyanate in the procedure of example 1 , but otherwise following the procedure of example 1 , resulted in the formation of the title compound as crystals ( m . p ., 135 °- 136 ° c .). anal . calc &# 39 ; d for c 17 h 20 n 2 o 2 : c , 71 . 81 ; h , 7 . 09 ; n , 9 . 85 . found : c , 72 . 06 ; h , 7 . 18 ; n , 9 . 90 . substitution of an equivalent quantity of 3 - methoxyphenyl isocyanate for cyclohexyl isocyanate in the procedure of example 1 , but otherwise following the procedure of example 1 , resulted in the formation of the title compound as crystals ( m . p ., 142 °- 144 ° c .). anal . calc &# 39 ; d for c 18 h 22 n 2 o 3 : c , 68 . 77 ; h , 7 . 05 ; n , 8 . 91 . found : c , 68 . 64 ; h , 7 . 12 ; n , 8 . 90 . substitution of an equivalent quantity of 2 - chlorophenyl isocyanate for cyclohexyl isocyanate in the procedure in example 1 , but otherwise following the procedure of example 1 , resulted in the formation of the title compound as crystals ( m . p ., 136 °- 138 ° c .). anal . calc &# 39 ; d for c 17 h 19 cln 2 o 2 : c , 64 . 05 ; h , 6 . 01 ; cl , 11 . 12 ; n , 8 . 79 . found : 64 . 08 ; h , 6 . 08 ; cl , 11 . 02 ; n , 8 . 74 . substitution of an equivalent quantity of 4 - bromophenyl isocyanate for cyclohexyl isocyanate in the procedure in example 1 , and substitution of ethanol for ether - hexane as the recrystallization solvent in that procedure , but otherwise following the procedure of example 1 , resulted in the formation of the title compound as crystals ( m . p ., 164 °- 166 ° c .). anal . calc &# 39 ; d for c 17 h 19 brn 2 o 2 : c , 56 . 21 ; h , 5 . 27 ; br , 22 . 00 ; n , 7 . 71 . found : c , 56 . 12 ; h , 5 . 40 ; br , 22 . 29 ; n , 7 . 69 . substitution of an equivalent quantity of benzylisocyanate for cyclohexyl isocyanate in the procedure in example 1 , and substitution of hexane for ether - hexane as the recrystallization solvent in that procedure , but otherwise following the procedure of example 1 , resulted in the formation of the title compound as crystals ( m . p ., 112 °- 114 ° c .). anal . calc &# 39 ; d for c 18 h 22 n 2 o 2 : c , 72 . 46 ; h , 7 . 43 ; n , 9 . 39 . found : c , 72 . 50 ; h , 7 . 49 ; n , 9 . 38 . the anti - inflammatory properties of various compounds of this invention were determined by a carrageenan - induced paw edema test . male sprague - dawley rats weighing 160 - 200 g were used in the test . each compound to be tested was suspended in a 0 . 5 % solution of methocel in water and then orally administered to a group of six rats . control rats were orally administered an equivalent volume of a control solution : a 0 . 5 % solution of methocel in water . two hours after the administration of either the compound or the control solution , paw edema was induced by subcutaneous injection of 0 . 1 ml of a 1 . 0 % homogenized suspension of carrageenan into the plantar surface of the right hind paw . immediately after the injection of carrageenan , the volume of the right hand paw was determined by immersing it in mercury and measuring the volume of mercury that was displaced . two hours after the injection of carrageenan , the right hind paw volume was measured again . the percent inhibition of edema by a test compound was defined as [ 100 ×( a - b )/ a ] where a is the increase in paw volume in control rats during the two - hour period following carrageenan injection and b is the increase in paw volume , in rats administered the test compound , in the two - hour period following carrageenan injection . using oral doses of 50 mg / kg . a 20 % inhibition of edema was observed for tricyclo [ 3 . 3 . 1 . 1 3 , 7 ] decan - 2 - one o -[( cyclohexyl ) aminocarbonyl ] oxime , a 24 . 6 % inhibition was observed for tricyclco [ 3 . 3 . 1 . 1 3 , 7 ] decan - 2 - one o -( phenylaminocarbonyl ) oxime , a 29 . 8 % inhibition was observed for tricyclo [ 3 . 3 . 1 . 1 3 , 7 ] decan - 2 - one o -[( 3 - methoxy ) aminocarbonyl ] oxime , and a 28 . 1 % inhibition was observed for tricyclo [ 3 . 3 . 1 . 1 3 , 7 ] decan - 2 - one o -[( 2 - chlorophenyl ) aminocarbonyl ] oxime . the following compounds , when added at a concentration of 500 ug / ml to the supporting agar medium , prevented the growth of the fungus , e . floccosum : tricyclo [ 3 . 3 . 1 . 1 3 , 7 ] decan - 2 - one o -[( cyclohexyl ) aminocarbonyl ] oxime , tricyclo [ 3 . 3 . 1 . 1 3 , 7 ] decan - 2 - one o -( phenylaminocarbonyl ) oxime , tricyclo [ 3 . 3 . 1 . 1 3 , 7 ] decan - 2 - one o -[( 2 - chlorophenyl ) aminocarbonyl ] oxime , tricyclo [ 3 . 3 . 1 . 1 3 , 7 ] decan - 2 - one o -[( 4 - bromophenyl ) aminocarbonyl ] oxime , and tricyclo [ 3 . 3 . 1 . 1 3 , 7 ] decan - 2 - one o -[ benzylaminocarbonyl ] oxime .
novel 2 - adamantanone oxime carbamate derivatives , including tricyclodecan - 2 - one o - aminocarbonyl ] oxime , tricyclodecan - 2 - one o - aminocarbonyl ] oxime , and tricyclodecan - 2 - one o - aminocarbonyl ] oxime ; useful as antifungal agents against e . floccosum .